Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCabe

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Nature Reviews. Clinical Oncology|May 16, 2018
Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham Mailankody
Pharmacoeconomics|November 14, 2009
Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expectedAllan Wailoo, Aki Tsuchiya, Christopher McCabe
Pharmacoeconomics|March 7, 2014
Achieving allocative efficiency in healthcare: nice in theory, not so NICE in Practice?Mike Paulden, Christopher McCabe, Jonathan Karnon
Trends in Cancer|August 29, 2018
Balancing the Economics and Ethics of Personalised OncologyNicola Flaum, Peter Hall, Christopher McCabe
BMJ (Clinical Research Ed.)|October 29, 2005
Orphan drugs and the NHS: should we value rarity?Christopher McCabe, Karl Claxton, Aki Tsuchiya
Nature Reviews. Clinical Oncology|November 14, 2018
Addendum: Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham Mailankody
Pharmacoeconomics|September 5, 2008
The NICE cost-effectiveness threshold: what it is and what that meansChristopher McCabe, Karl Claxton, Anthony J Culyer
Pharmacoeconomics|December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and MedicineMike Paulden, James F O'Mahony, Christopher McCabe
Physical Review Letters|September 22, 2018
Directly Detecting Sub-GeV Dark Matter with Electrons from Nuclear ScatteringMatthew J Dolan, Felix Kahlhoefer, Christopher McCabe
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Use of visual analog scales in economic evaluationJohn Brazier, Colin Green, Christopher McCabe, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Nature Reviews. Clinical Oncology|May 16, 2018
Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham Mailankody
Pharmacoeconomics|November 14, 2009
Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expectedAllan Wailoo, Aki Tsuchiya, Christopher McCabe
Pharmacoeconomics|March 7, 2014
Achieving allocative efficiency in healthcare: nice in theory, not so NICE in Practice?Mike Paulden, Christopher McCabe, Jonathan Karnon
Trends in Cancer|August 29, 2018
Balancing the Economics and Ethics of Personalised OncologyNicola Flaum, Peter Hall, Christopher McCabe
BMJ (Clinical Research Ed.)|October 29, 2005
Orphan drugs and the NHS: should we value rarity?Christopher McCabe, Karl Claxton, Aki Tsuchiya
Nature Reviews. Clinical Oncology|November 14, 2018
Addendum: Low-value approvals and high prices might incentivize ineffective drug developmentVinay Prasad, Christopher McCabe, Sham Mailankody
Pharmacoeconomics|September 5, 2008
The NICE cost-effectiveness threshold: what it is and what that meansChristopher McCabe, Karl Claxton, Anthony J Culyer
Pharmacoeconomics|December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and MedicineMike Paulden, James F O'Mahony, Christopher McCabe
Physical Review Letters|September 22, 2018
Directly Detecting Sub-GeV Dark Matter with Electrons from Nuclear ScatteringMatthew J Dolan, Felix Kahlhoefer, Christopher McCabe
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Use of visual analog scales in economic evaluationJohn Brazier, Colin Green, Christopher McCabe, et al.
Pageof 15